| Date Filed | Type | Description |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/16/2021 |
4
| KING STEVEN W (Director) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Converted 3,291,720 shares
@ $0
Converted 3,292 convertible preferred
@ $0
Granted 357,412 options
@ $0.1626, valued at
$58.1k
|
|
| 01/29/2021 |
4
| KING STEVEN W (President and CEO) has filed a Form 4 on Mosaic ImmunoEngineering Inc.|
Txns:
| Converted 1,641,252 shares
@ $0
Converted 161,000 options to buy
@ $0 |
|
| 12/16/2020 |
4
| KING STEVEN W (President and CEO) has filed a Form 4 on Mosaic ImmunoEngineering Inc.|
Txns:
| Granted 65,218 restricted stock units
@ $3.3, valued at
$215.2k
Granted 43,479 restricted stock units
@ $3.3, valued at
$143.5k
|
|
| 08/31/2020 |
3
| KING STEVEN W (President and CEO) has filed a Form 3 on PATRIOT SCIENTIFIC CORP |
| 05/21/2020 |
3
| KING STEVEN W (Director) has filed a Form 3 on MATEON THERAPEUTICS INC |
| 11/01/2017 |
4
| KING STEVEN W (President & CEO) has filed a Form 4 on PEREGRINE PHARMACEUTICALS INC|
Txns:
| Acquired 1,398 shares
@ $3.8675, valued at
$5.4k
|
|
| 04/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/01/2016 |
4
| KING STEVEN W (President & CEO) has filed a Form 4 on PEREGRINE PHARMACEUTICALS INC|
Txns:
| Acquired 18,826 shares
@ $0.2864, valued at
$5.4k
|
|
| 06/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/01/2013 |
4
| KING STEVEN W (President & CEO) has filed a Form 4 on PEREGRINE PHARMACEUTICALS INC|
Txns:
| Acquired 4,131 shares
@ $1.08, valued at
$4.5k
|
|
| 10/17/2013 |
4
| KING STEVEN W (President & CEO) has filed a Form 4 on PEREGRINE PHARMACEUTICALS INC|
Txns:
| Granted 100,000 shares
@ $0
Disposed/sold 250,000 options to buy
@ $0.46, valued at
$115k
Granted 250,000 options to buy
@ $1.39, valued at
$347.5k
|
|
| 05/08/2013 |
4
| KING STEVEN W (President & CEO) has filed a Form 4 on PEREGRINE PHARMACEUTICALS INC|
Txns:
| Granted 400,000 options to buy
@ $1.41, valued at
$564k
|
|
| 05/01/2013 |
4
| KING STEVEN W (President & CEO) has filed a Form 4 on PEREGRINE PHARMACEUTICALS INC|
Txns:
| Acquired 6,516 shares
@ $0.71, valued at
$4.6k
|
|
| 11/01/2012 |
4
| KING STEVEN W (President & CEO) has filed a Form 4 on PEREGRINE PHARMACEUTICALS INC|
Txns:
| Acquired 11,000 shares
@ $0.39, valued at
$4.3k
|
|
| 05/08/2012 |
4
| KING STEVEN W (President & CEO) has filed a Form 4 on PEREGRINE PHARMACEUTICALS INC|
Txns:
| Granted 500,000 options to buy
@ $0.46, valued at
$230k
|
|
| 05/01/2012 |
4
| KING STEVEN W (President & CEO) has filed a Form 4 on PEREGRINE PHARMACEUTICALS INC|
Txns:
| Acquired 10,726 shares
@ $0.4, valued at
$4.3k
|
|
| 02/21/2012 |
4
| KING STEVEN W (President & CEO) has filed a Form 4 on PEREGRINE PHARMACEUTICALS INC|
Txns:
| Granted 82,561 options to buy
@ $0.95, valued at
$78.4k
Granted 267,439 options to buy
@ $0.95, valued at
$254.1k
|
|
| 11/02/2011 |
4
| KING STEVEN W (President & CEO) has filed a Form 4 on PEREGRINE PHARMACEUTICALS INC|
Txns:
| Acquired 4,804 shares
@ $0.89, valued at
$4.3k
|
|
| 07/05/2011 |
4
| KING STEVEN W (President & CEO) has filed a Form 4 on PEREGRINE PHARMACEUTICALS INC|
Txns:
| Disposed/sold 14,000 shares
@ $0 |
|
| 02/11/2011 |
4
| KING STEVEN W (President & CEO) has filed a Form 4 on PEREGRINE PHARMACEUTICALS INC|
Txns:
| Granted 14,000 shares
@ $0 |
|
| 01/04/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/24/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/03/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |